No. | Author | Years | Country | Age | Sex | Etiology of ESRD | Time on dialysis | Antiplatelets | Anticoagulants | Laterality | Treatment | Outcome | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Delorme MA | 1993 | Canada | 68 | M | CGN | 6 years | None | None | ND | ND | ND | [5] |
2 | Inoue T | 2001 | Japan | 76 | F | ND | ND | ND | ND | L | Conservative | Death | [6] |
3 | Halak M | 2001 | Israel | 72 | F | ND | ND | None | Heparin | L | Endovascular Tx | Survival | [7] |
4 | Malek-MarÃn T | 2010 | Spain | 76 | M | ADPKD | 18 years | None | Warfarin | R | Conservative | Survival | [8] |
5 | Fan WX | 2012 | China | 67 | F | DMN | 2 weeks | Ozagrel | Heparin | L | Conservative | Survival | [11] |
6 | Li J | 2016 | Hong Kong | 72 | M | ND | 5 years | Aspirin, clopidogrel | LMWH | R | Endovascular Tx | Survival | [9] |
7 | Hwang NK | 2017 | Korea | 43 | M | ND | ND | ND | Heparin | L | Endovascular Tx | Survival | [10] |
8 | 69 | F | ND | ND | Aspirin, clopidogrel | Heparin | L | Endovascular Tx | Death | ||||
9 | 48 | M | ND | 4 months | Aspirin, clopidogrel, pletaal | LMWH | R | Endovascular Tx | Survival |